Killian Meara

Narcan is set to be available at several drugstore and grocery chains in the US early next week, and Walmart announced a new "Testing and Treatment" program at its pharmacies in 12 states.

Serotonin reuptake inhibitors (SSRIs) are the preferred medication to treat postnatal depression, but there is a lack of evidence about their long-term impact on women and their children.

CMS announces the first 10 drugs selected for price negotiation under Medicare Part D, and a new study finds prescriptions for fruits and vegetables can improve health outcomes for people at increased risk of cardiovascular disease.

A recent systematic review found no serious adverse events related to the use of cannabis for the management of cancer-related symptoms in children.

Although investigators found a lack of strong evidence to support CGM programs in community pharmacy settings, studies in ambulatory care settings suggest that these programs are both feasible and beneficial.

The new deadline to be in compliance with the requirements will be November 27, 2024.

HHS awards money for mental health awareness training, UnitedHealthcare pays $80,000 over potential HIPPA violation, and the FDA issues a recall for sub-acute care ventilators.

A new study found that 34% of the chatbot’s answers included 1 or more recommendation that did not align with clinical guidelines.

CVS Health joins the biosimilar market, the FDA issues warning about contaminated eye drops, and the CDC says not to kiss your pet turtle because of salmonella.

The CDC and WHO are currently tracking several variants that are driving the majority of new cases around the world.

One in 5 women report mistreatment during maternity care, employers see rise in mental health challenges, and Microsoft teams up with Epic to increase the use of AI in healthcare.

The respiratory syncytial virus vaccine (Abrysvo) is the first and only maternal RSV vaccine used to help protect infants from the virus.

Poll finds Americans still struggle with health misinformation, CMS release new guidance on out-of-pocket Prescription Drug Cost Program, and experts call for continued masking in health care settings.

A recent study found that Infants younger than 3 months, those born prematurely, and those who were publicly insured were at a higher risk for intubation.

Investigators said the findings show how efforts to encourage more people to get recommended cancer checks are crucial.

A Q&A with Matt Sample, senior vice president of manufacturer and replenishment operations at AmerisourceBergen.

NIH establishes research centers for maternal health, FDA grants priority review for IgA nephropathy treatment, and the CDC begins tracking a new COVID-19 variant.

Appeals court puts restrictions on access to mifepristone, Blue Shield of California drops CVS Health, and Americans think opioids and obesity are the 2 biggest threats to public health.

National organizations call for Improvements to youth mental health care, Wednesday marks 1 year since passing of Inflation Reduction Act, and a new study finds link between fracking and lymphoma.

Philips recall declared class I by the FDA, HHS launches civil rights investigation into Tennessee medical center, and experts warn about chemicals released into air and water during Maui wildfires.

HHS awards money to fight the nursing shortage, the FDA approves Johnson & Johnson's talquetamab-tgvs (TALVEY), and the CDC says suicides reached an all-time high in 2022.

WHO upgrades EG.5 to "variant of interest," Amazon-owned One Medical expands across US, and health officials urge vaccination before the coming fall season.

A recent study being presented at the American College of Cardiology Latin America 2023 conference found the prevalence of cardiotoxicity among patients with breast cancer undergoing chemotherapy was 11.94%.

COVID-19 hospitalizations tick up, Wegovy shows cardiovascular benefit, and health care organizations team up to fight overdose deaths in New Jersey.

Omicron EG.5 COVID-19 variant takes hold in the US, new inclusive blood donation guidance goes into effect, and the national uninsured rate reaches a new all-time low.

Moderna’s mRNA-1273 vaccine was associated with a lower risk of diagnosed COVID-19 when compared to Pfizer’s BNT162b2.

A Q&A with Marc Ost, co-owner of Eric’s RX Shoppe, which was one of the first community pharmacies to receive the new vaccine.

Zavegepant (Zavzpret) is the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray approved by the FDA for acute migraine treatment in adults.

A recent study determined over 12,000 screenings would need to be done to identify 1 case of melanoma in racial and ethnic minority populations.

A minimum dose of 3.4 to 3.6 minutes of vigorous intermittent lifestyle physical activity per day was associated with a 17% to 18% reduction in total incident cancer risk.